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ABSTRACT
Background: The transmission of Yellow fever,a viral hemorrhagic feveris facilitated in countries which have close 
proximity to the mosquito vectors and large number of unvaccinated population.  Globally, mass vaccination campaigns 
have significantlyreduced the incidence of this disease, but recent reports from the World Health Organization (WHO), 
indicates an increase in the rate of transmission, especially in Sub-Saharan Africa. Between 2017 and 2018,some Nigerian 
states including Plateau state reported confirmed cases of yellow fever. In this study, we assessed the yellow fever 
immunization coverage in Jos North Local Government area (LGA) of Plateau state.
Methodology: A retrospective cross-sectional study was carried out to assess yellow fever immunization coverage in Jos 
North LGA over a 3-year period from January 2015 to December 2017, with data obtained from the Local Government 
Area office. This included both data from routine and supplemental immunization activities. The number of children 
immunized was then compared to the target population to assess coverage for each year.
Results: Overall, 71, 734 children were immunized. This comprised of infants 9-11 months 69,344(96.7%) and 1 -5 year 
old infants 2390(3.3%). The overall average immunization coverage was (21,514/92,652) 23.2% in 2015, (24,977/93,569) 
26.6% in 2016, and (25,243/94,495) 26.7% in 2017, with a mean coverage of 25.5% over the 3 year period.
Conclusion: Yellow fever immunization coverage in this LGA is low. Urgent work needs to be done to increase 
immunization coverage across the local government, and by extension the state and country, especially in view of the 
recent outbreak of yellow fever in some states. 
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ellow fever virus is one of the many 
causes of viral hemorrhagic fever. It Yis a member of the flavivirus family 
(group B arbovirus). A mosquito-borne 
disease, yellow fever can manifest as a 
spectrum of presentations, ranging from 
asymptomatic illness to acute-onset viral 
hepatitis and hemorrhagic fever. It is 
transmitted by tree-hole breeding 
mosquitoes (Haemagogus and Aedes species) 
during the tropical wet season and early dry 
season. Large vaccination campaigns and A. 
aegypti control programs have decreased the 
incidence of yellow fever worldwide. 
Nonetheless, yellow fever has re-emerged 
across Africa and South America, despite 
the availability of an effective live-
attenuated 17D vaccine. 
The populations at highest risk for the 
illness are those in countries that lack the 
funding and infrastructure to support a 
widespread vaccination program. World 
Health Organization (WHO) data suggest 
that the rate of yellow fever transmission is 
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increasing, especially in sub-Saharan 
Africa. Ninety percent of reported cases 
occur in Africa, where A. aegypti is rampant. 
T r a n s m i s s i o n  o c c u r s  i n  l a r g e l y  
unvaccinated populations of sub-Saharan 
Africa. The countries at greatest risk lie 
within a band from 15° North to 10° South of 
the equator. This region includes 32 
countries in sub-Saharan Africa.  
The case-fatality rate of yellow fever in 
Africa approximates 20% with infants and 
children being at highest risk. Yellow fever 
is a vaccine preventable disease, and despite 
it being scheduled on the National 
Programme on Immunization (NPI) in 
Nigeria, the immunization coverage is said 
to be low, with the WHO estimating that 
about 23 million children are at risk in urban 
areas only. The Global Alliance for Vaccines 
and Immunization (GAVI) puts the routine 
immunization coverage for yellow fever in 
Nigeria at just 51% in 2016. As of 2007, 
yellow fever immunization coverage in 12 
to 23 month old Nigerian children was 
highest in Enugu state, with a coverage of 
92.7 %. The other top 5 immunization 
coverage regions included Osun, Kwara, 
Nassarawa, and Oyo states, with Oyo state 
having a coverage of 63% in 2014. According 
to the Nigeria Centre for Disease 
Control(NCDC),  sixteen Nigerian states 
including Plateau state, reported suspected 
cases of yellow fever as at October 2017, 
with  confirmed cases from six states. This 
s tudy  assessed  the  ye l low fever  
immunization coverage in a local 




Aretrospective cross-sectional study was 
carried out, assessing the records of yellow 
fever immunization in the local government 
over a three-year period of January 2015 to 
December 2017.
Study area
Jos North LGA was chosen for this study, 
because the two cases of yellow fever 
reported from Plateau state in the 2017 
outbreak were from this local government. 
B o t h  r o u t i n e  a n d  s u p p l e m e n t a l  
immunization activities are carried out in 
this LG in accordance with the National 
programme on immunization. Jos North 
LGA is the administrative seat of 
government in Plateau state. It has an area of 
about 291km2, and a population of about 
573,000 as at 2016, 50.1% of which are 
14females, while 49.9% are males . The major 
occupation here as in other LGA in Plateau 
state, is farming, but there are also various 
kinds of industries, trading in different 
goods and services, and significant number 
of civil servants, due to it being the state 
capital. Both Christianity and Islam is 
practiced by people in this LGA, and the 
major languages include Hausa, Berom, 
English amongst others. 
Data processing or Management
Immunization data was identified, 
retrieved and serialized from the Local 
Government Area office. The immunized 
population of children between 9-11 
months of age, as well as those between 1-5 
years of age was then compared to the 
estimated target population of children 
between the same ages in the local 
government, to get the proportion of the 
population that had been immunized 
against yellow fever. Total population was 
obtained using documented projections of 
population trends from the last national 
census. The target population for yellow 
fever was calculated using the formula: 
0.5% of the total population for children 
aged 9 – 11 months, and 16% of the total 
population for children aged 1 – 5 years old. 
Immunizat ion coverage was then 
calculated, using the total population 
immunized as the numerator, while the 
target population was used as the 
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coverage was 25.5%. There is a statistically 
significant difference in the immunization 
coverage over the 3 year period, with a p 
value of <0.0000001
Discussion
Plateau state reported two yellow fever 
cases in the 2017/2018 outbreak, both from 
Jos North LGA.In this study, we present the 
immunization coverage in this local 
government over a three year period. The 
study showed a low immunization 
coverage in the target population of the 
Local Government Area. This is consistent 
with the WHO estimates of the total 
population immunity for yellow fever in 
Nigeria as being low (35.4%). This is 
worrisome, as there is a critical herd 
immunity needed to prevent yellow fever 
transmission in a particular area. This was 
reflected in the 2017 outbreak in Nigeria, 
with suspected cases reported from at least 
16 states, and confirmed cases from 6 states. 
Low immunization coverage as reported 
from this study, is likely responsible for the 
low population immunity against yellow 
fever. This is very much below the herd 
immunity thresholds of 60 – 80%, and could 
predispose to spontaneous outbreaks of the 
disease. Especially so, considering what is 
needed for effective transmission is the 
close proximity of vector mosquito 
populations to unvaccinated human 
populations. 
Data from this study and the recent 
outbreak of the disease, shows that we have 
a large percentage of unvaccinated 
population. Effective response to the 
outbreak by WHO and NCDC, including 
supporting local authorities, strengthening 
surveillance and laboratory capacities, and 
a recent large scale exercise carried out in 
Lagos to assess readiness , as well as mass 
vaccination campaigns currently being 
carried out across the country suggest that 
this trend could be reversed.  Emphasis 
though, would have to be placed on areas 
.
denominator. Chi square for trends was 
used to assess for statistical significance in 
the results over the 3 year period. Inclusion 
criteria comprised all data on childhood 
yellow fever vaccination from January 2015 
to December 2017, including both routine 
and supplemental immunizations. Data 
outside this time period, as well as adult 






















































































Table 1 above shows the total number of 
children under 5 years of age that received 
immunizations for yellow fever for each 
year from 2015 to 2017. These includes data 
for children who were immunized in 
immunization clinics, and those immunized 
during special outreaches of the Expanded 
Programme on Immunization (EPI). It also 
shows the yellow fever immunization 
coverage for the local government over the 
same time period. The mean immunization 
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with low documented immunization 
coverage.
Common reasons that have been put 
forward for poor immunization coverage 
around the country includes shortage of 
vaccines and injection supplies, problems 
with constant electricity supply and the 
maintenance of the cold chain, poor 
government support for these programmes 
in terms of releasing funds, and recurrent 
health workers strikes. Other factors 
include low literacy rates among the 
population, especially among females, 
mothers not having time, cultural and 
religious factors that impede immunization 
uptake among others. 
A comprehensive review of the yellow fever 
cases in Nigeria is needful. This would 
involve determination or otherwise of the 
status of yellow fever immunization of the 
affected persons using their personal 
immunization records or yellow cards. This 
would help in determining factors that 
affect failure of immunization.
This study has some limitation, first, 
a s s e s s i n g  t h e  u p t a k e  o f  o t h e r  
immunizations e.g measles, which is given 
at the same time, might have given a more 
robust view of immunization uptake in the 
LGA. Also qualitative methods of 
assessments like focused group discussions 
or key informant interviews, might have 
elucidated the real reasons for the low 
coverage. A target population of 16.5% of 
the total population was used for this study 
using the formula for the different age 
ranges, 9-11 months, and 1-5 years in this 
case.  Assessing the target population for 
age range 1-2 years, instead of 1-5years, 
might have given a more accurate 
description as this is the age range at which 
yellow fever vaccination is usually given, 
although children under 5 years are 
generally targeted during extended 
p r o g r a m m e s  o n  i m m u n i z a t i o n .  
Additionally, adult immunization coverage 
was not determined, which would have 
given the complete immunization status of 
the local Government Area.
Conclusion
The 2017 outbreak was a reminder to the 
harsh truth that at present, we are prone to 
having outbreaks of yellow fever due to the 
low yellow fever immunization coverage, 
and a lot of urgent work needs to be done to 
forestall this. This would be especially 
important in this local government, and by 
extension the Nation.  Significant work still 
needs to be done to raise public awareness 
about the disease, and its means of spread, 
facilitate a steady supply of vaccines, with 
proper storage facilities, including strict 
maintenance of the cold chain, and address 
cultural and religious factors impeding 
adequate uptake of immunization. Records 
of immunization should also be taken more 
seriously for adequate documentation, and 
further  work done to  assess  the  
immunization coverage across the state, 
and the country at large. These would be 
important to increase the total population 
immunity against the virus, and approach 
levels needed for herd immunity, thereby 
reducing the risk of outbreaks.
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